Further in vivo studies had shown that glycitein affected glioblastoma cells by reducing the activity of matrix metalloproteinase-3 (MMP-3), nuclear transcription factor (NF-κB), and AP-1 [79]. Here, MMP3 is linked to glioblastoma.